N-cadherin Overexpression Enhances the Reparative Potency of Human iPSC-Derived Cardiac Myocytes in Infarcted Mouse Hearts.
In regenerative medicine, cellular cardiomyoplasty is one of the promising options for treating myocardial infarction (MI); however, the efficacy of such treatment has shown to be limited due to poor survival and/or functional integration of implanted cells. Within the heart, the adhesion between cardiac myocytes (CMs) is mediated by N-cadherin (CDH2), and is critical for the heart to function as an electromechanical syncytium. In this study, we have investigated whether the reparative potency of human induced pluripotent stem cell-derived cardiac myocytes (hiPSC-CMs) can be enhanced through CDH2 overexpression. CDH2-hiPSC-CMs and control WT-hiPSC-CMs were cultured in myogenic differentiation medium for 28 days. Using a mouse MI model, the cell survival/engraftment rate, infarct size, and cardiac functions were evaluated post MI, at day 7 or day 28. In vitro, conduction velocities were significantly greater in CDH2-hiPSC-CMs than in WT-hiPSC-CMs. While, in vivo, measurements of cardiac functions: left-ventricular (LV) ejection fraction, reduction in infarct size, and the cell engraftment rate were significantly higher in CDH2-hiPSC-CMs treated MI group than in WT-hiPSC-CMs treated MI group. Mechanistically, paracrine activation of ERK signal transduction pathway by CDH2-hiPSC-CMs, significantly induced neo-vasculogenesis, resulting in a higher survival of implanted cells. Collectively, these data suggest that CDH2 overexpression enhances not only the survival/engraftment of cultured CDH2-hiPSC-CMs, but also the functional integration of these cells, consequently, the augmentation of the reparative properties of implanted CDH2-hiPSC-CMs in the failing hearts. Our study proposes to combine cellular cardiomyoplasty with gene therapy to improve LV function and remodeling after MI. The reparative potency of hiPSC-CMs could be enhanced through CDH2 overexpression. This unique approach displays several features required for clinical application, which would open new perspectives in clinical setting for the effective management of MI, and thus, can lead to functional enhancement of a failing heart.